TAK
Takeda Pharmaceutical Co Ltd
17.40$
-0.1%
vs. previous close
Closing price · As of: Aug 13, 2026
Statements
Cash Flow
All figures per share in JPY.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 63.54 | 46.20 | 88.81 | 53.59 | 87.25 | 121.06 | 70.23 | 67.82 | 119.88 | 116.46 | 23.85 | 39.76 | 297.13 | |
| 58.36 | 59.01 | 59.53 | 60.48 | 59.77 | 58.98 | 59.99 | 57.18 | 58.63 | 59.48 | 52.44 | 50.80 | 218.90 | |
| 5.92 | 5.90 | 5.80 | 4.84 | 6.69 | 5.77 | 5.57 | 5.20 | 5.94 | 5.55 | 6.31 | 5.67 | 23.19 | |
| -1.59 | – | – | – | – | – | – | – | – | – | – | – | – | |
| 0.51 | -52.37 | 18.93 | -25.23 | -21.99 | 28.00 | 0.91 | -10.61 | 6.95 | -12.27 | 80.32 | -49.44 | 23.35 | |
| 22.37 | 24.33 | 20.51 | 48.30 | 28.71 | 17.87 | 29.31 | 23.63 | 16.74 | 69.38 | 20.61 | 16.77 | 122.58 | |
| -104.49 | -23.74 | -19.60 | -49.30 | -23.33 | -36.45 | -6.22 | -10.45 | -15.26 | -71.70 | -18.57 | -27.33 | -132.00 | |
| 2.90 | 43.61 | 2.91 | 43.46 | 2.86 | 45.88 | 3.08 | 45.74 | 2.79 | 46.50 | 2.81 | 46.78 | 98.69 | |
| -0.74 | 0.00 | -0.60 | -0.59 | -0.58 | -0.59 | -15.80 | -16.25 | 0.00 | 0.30 | 0.42 | -0.31 | 0.40 | |
| -50.17 | – | – | – | -21.60 | -148.54 | -64.33 | 0.01 | 11.59 | -3.08 | -8.20 | – | – | |
| -44.93 | -30.84 | -18.56 | 99.55 | -34.17 | -206.93 | -95.41 | -67.66 | -3.80 | -60.05 | -24.80 | -56.19 | -144.03 | |
| 0.53 | -9.37 | 54.01 | 109.25 | 16.77 | -115.11 | -34.46 | -11.05 | 105.07 | -8.28 | -19.16 | -41.77 | 34.58 | |
| 41.16 | 21.87 | 68.30 | 5.29 | 58.54 | 103.19 | 40.92 | 44.19 | 103.14 | 47.08 | 3.24 | 23.00 | 174.56 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: August 13, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.